Skip to main content

Table 1 Immunoreactivity of VEGF according to clinicopathologic characteristics of the cervical carcinoma patients

From: Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

  No. of patients VEGF expression  
Variables   Positive Negative P
Total 29 15 14  
Age     
   ≥50 years 12 7 5 0.55
   < 50 years 17 8 9  
Stage     
   IB2 20 9 11 0.28
   IIA 9 6 3  
Cervical tumor size     
   ≥5 cm 14 9 5 0.19
   < 5 cm 15 6 9  
Clinical node involvement     
   Yes 11 7 4 0.32
   No 18 8 10  
SCC Ag level     
   ≥5 ng/ml 14 8 6 0.57
   < 5 ng/ml 15 7 8  
  1. a(n = 29)
  2. aThe P-value was determined using Chi-square test or Fisher's exact test.